Carter's (CRI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Jul, 2026Executive summary
Net sales for Q2 2026 rose 5.2% year-over-year to $615.5 million, with growth across all segments and strong e-commerce momentum.
Operating income surged to $140 million from $4 million in Q2 2025, driven by a $128–$132 million tariff/import duty recovery; adjusted operating income increased 54% to $18 million.
Net income for Q2 2026 was $105 million ($2.87 per diluted share), up from $0.4 million; adjusted net income was $9.4 million ($0.26 per share), up 49%.
U.S. Retail comparable sales rose 5.1%, supported by improved marketing and productivity initiatives.
Leadership transition completed with a new CEO appointed; IP litigation and transition costs impacted results.
Financial highlights
Q2 2026 consolidated net sales: $615.5 million (+5.2% YoY); gross margin: 67.0% (GAAP), 46.3% (adjusted); operating margin: 22.7% (GAAP), 2.9% (adjusted).
SG&A expenses decreased 1.7% to $276.1 million; SG&A rate improved by 310 bps to 44.9%.
EBITDA for Q2 2026: $152.5 million (GAAP), $30.8 million (adjusted).
First half 2026 net sales: $1.30 billion (+6.7% YoY); net cash from operations: $202.3 million, up from a $8.3 million outflow in H1 2025.
Cash and cash equivalents at quarter-end: $653.6 million.
Outlook and guidance
FY 2026 net sales expected to grow 2–3%; adjusted operating income projected to grow low- to mid-single digits; adjusted EPS to decline high single- to low double-digits.
Q3 2026 guidance: ~$750 million net sales, ~$50 million adjusted operating income, ~$0.85 adjusted EPS.
Operating cash flow forecasted at $230–$240 million; capital expenditures at $50 million.
Board will evaluate future dividends based on business conditions and financial performance.
Earnings contributions weighted to the second half due to tariff and investment timing.
Latest events from Carter's
- Net sales up 8.1% to $681M, but margins and EPS fell on tariffs and higher costs.CRI
Q1 2026 - CEO transition prompts board nominee update; only eight nominees stand for re-election.CRI
Proxy filing - Board recommends all proxy proposals, emphasizing pay-for-performance and strong governance.CRI
Proxy filing - Proxy statement solicits shareholder votes for the annual meeting with no major transactions proposed.CRI
Proxy filing - Sales grew in Q4 and FY25, but margins and EPS fell; FY26 outlook cautious amid tariff uncertainty.CRI
Q4 2025 - Q3 sales and profit fell but beat guidance; full-year EPS outlook and liquidity were raised.CRI
Q3 2024 - Q2 sales fell 6% but margins and EPS improved; FY 2024 outlook lowered on retail weakness.CRI
Q2 2024 - Omni-channel growth, store innovation, and pricing clarity drive a positive second-half outlook.CRI
4th Annual Evercore ISI Consumer and Retail Conference - Q1 2025 sales and earnings declined, with guidance suspended amid macro and tariff risks.CRI
Q1 2025